VAN ECK ASSOCIATES CORP

Position in BIIB — Biogen Inc.

CIK 869178 NEW YORK, NY

Back to BIIB Full portfolio

Position in BIIB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$197,970,916

+$10,433,157 QoQ

Shares Held

1,079,861

+1.3% QoQ

Ownership

0.731%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

VAN ECK ASSOCIATES CORP holds $2,742,510,249 across 15 Drug Manufacturers - General names. BIIB ranks #5 (7.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	10,257,215	$622,100,088
2	PFE	Pfizer Inc	16,301,030	$457,732,922
3	LLY	ELI LILLY & Co	439,012	$403,790,067
4	MRK	Merck & Co., Inc.	1,792,705	$215,644,484
5	BIIB	Biogen Inc. This page	1,079,861	$197,970,916
6	JNJ	Johnson & Johnson	736,828	$180,110,235
7	GILD	Gilead Sciences, Inc.	1,204,597	$167,884,683
8	NVS	Novartis AG	891,803	$136,222,908

All Filings in BIIB

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$197,970,916	1,079,861	+1.3%	Shares	Sole	2026-05-15
2025-12-31	$187,537,759	1,065,616	-0.1%	Shares	Sole	2026-02-13
2025-09-30	$149,455,694	1,066,931	-0.7%	Shares	Defined	2025-11-13
2025-06-30	$134,985,513	1,074,811	+0.1%	Shares	Defined	2025-08-14
2025-03-31	$146,914,434	1,073,622	+0.7%	Shares	Sole	2025-05-15
2024-12-31	$163,083,063	1,066,460	+977.9%	Shares	Sole	2025-01-29
2024-09-30	$19,177,948	98,937	-89.3%	Shares	Sole	2024-10-29
2024-06-30	$213,914,454	922,761	-46.9%	Shares	Defined	2024-07-31
2024-03-31	$374,622,623	1,737,340	+22.2%	Shares	Sole	2024-04-30
2023-12-31	$367,762,888	1,421,196	+19.5%	Shares	Defined	2024-02-05
2023-09-30	$305,725,217	1,189,546	+24.5%	Shares	Defined	2023-11-08
2023-06-30	$272,218,895	955,657	+17.9%	Shares	Sole	2023-08-03
2023-03-31	$225,309,394	810,378	+2.9%	Shares	Defined	2023-05-03
2022-12-31	$218,090,561	787,558	-14.2%	Shares	Sole	2023-02-08
2022-09-30	$245,102,262	917,986	-3.4%	Shares	Defined	2022-10-27
2022-06-30	$193,709,349	949,835	+1.3%	Shares	Defined	2022-08-03
2022-03-31	$197,517,106	937,878	+17.4%	Shares	Defined	2022-05-10
2021-12-31	$191,679,045	798,929	+24.8%	Shares	Defined	2022-01-26
2021-09-30	$181,134,823	640,075	+7.3%	Shares	Sole	2021-11-03
2021-06-30	$206,566,329	596,547	-4.4%	Shares	Sole	2021-08-10
2021-03-31	$174,576,309	624,044	+20.7%	Shares	Defined	2021-05-13
2020-12-31	$126,549,524	516,824	+18.7%	Shares	Sole	2021-02-09
2020-09-30	$123,519,377	435,418	+12.7%	Shares	Defined	2020-12-04
2020-06-30	$103,358,577	386,315	+10.7%	Shares	Defined	2020-08-14
2020-03-31	$110,378,970	348,881	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.